- Home
- NBIX vs ALB Comparison
NBIX vs ALB Comparison
Compare NBIX & ALB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- ALB
- Stock Information
- Founded
- NBIX 1992
- ALB 1994
- Country
- NBIX United States
- ALB United States
- Employees
- NBIX N/A
- ALB N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- ALB Major Chemicals
- Sector
- NBIX Health Care
- ALB Industrials
- Exchange
- NBIX Nasdaq
- ALB Nasdaq
- Market Cap
- NBIX 14.4B
- ALB 11.6B
- IPO Year
- NBIX 1996
- ALB 1994
- Fundamental
- Price
- NBIX $140.02
- ALB $92.65
- Analyst Decision
- NBIX Strong Buy
- ALB Hold
- Analyst Count
- NBIX 17
- ALB 17
- Target Price
- NBIX $164.94
- ALB $88.38
- AVG Volume (30 Days)
- NBIX 803.5K
- ALB 3.5M
- Earning Date
- NBIX 10-28-2025
- ALB 11-05-2025
- Dividend Yield
- NBIX N/A
- ALB 1.75%
- EPS Growth
- NBIX 2.97
- ALB N/A
- EPS
- NBIX 3.39
- ALB N/A
- Revenue
- NBIX $2,509,900,000.00
- ALB $4,993,278,000.00
- Revenue This Year
- NBIX $20.79
- ALB N/A
- Revenue Next Year
- NBIX $14.73
- ALB $7.49
- P/E Ratio
- NBIX $40.99
- ALB N/A
- Revenue Growth
- NBIX 18.42
- ALB N/A
- 52 Week Low
- NBIX $84.23
- ALB $49.43
- 52 Week High
- NBIX $154.61
- ALB $113.91
- Technical
- Relative Strength Index (RSI)
- NBIX 53.84
- ALB 56.37
- Support Level
- NBIX $136.71
- ALB $91.00
- Resistance Level
- NBIX $140.73
- ALB $99.49
- Average True Range (ATR)
- NBIX 3.35
- ALB 5.00
- MACD
- NBIX -0.34
- ALB 0.31
- Stochastic Oscillator
- NBIX 72.66
- ALB 64.93
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About ALB Albemarle Corporation
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.